FI962813A0 - IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen - Google Patents

IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen

Info

Publication number
FI962813A0
FI962813A0 FI962813A FI962813A FI962813A0 FI 962813 A0 FI962813 A0 FI 962813A0 FI 962813 A FI962813 A FI 962813A FI 962813 A FI962813 A FI 962813A FI 962813 A0 FI962813 A0 FI 962813A0
Authority
FI
Finland
Prior art keywords
stimulate
peripheral blood
mononuclear cells
blood mononuclear
cytolytic activity
Prior art date
Application number
FI962813A
Other languages
English (en)
Swedish (sv)
Other versions
FI962813A (fi
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI962813A0 publication Critical patent/FI962813A0/fi
Publication of FI962813A publication Critical patent/FI962813A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FI962813A 1994-01-20 1996-07-11 IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen FI962813A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (zh) 1994-01-20 1994-01-20 用白介素-10激活外周血单核细胞的细胞溶解活性
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (2)

Publication Number Publication Date
FI962813A0 true FI962813A0 (fi) 1996-07-11
FI962813A FI962813A (fi) 1996-07-11

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962813A FI962813A (fi) 1994-01-20 1996-07-11 IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen

Country Status (10)

Country Link
EP (1) EP0740552A1 (fi)
JP (1) JPH09508116A (fi)
CN (1) CN1142186A (fi)
AU (1) AU707019B2 (fi)
FI (1) FI962813A (fi)
NO (1) NO963029L (fi)
NZ (1) NZ259584A (fi)
PL (1) PL175343B1 (fi)
SK (1) SK91696A3 (fi)
WO (1) WO1995019780A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356010A1 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
RU2322452C2 (ru) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Иммуномодулирующая композиция
US20080081031A1 (en) 2006-09-28 2008-04-03 Schering Corporation Use of Pegylated IL-10 to Treat Cancer
CA2692282A1 (en) * 2007-06-27 2008-12-31 Joslin Diabetes Center, Inc. Regulatory t cells in adipose tissue
DK2379115T3 (da) 2008-12-17 2018-01-29 Merck Sharp & Dohme Fremstilling og anvendelse af mono- og di-PEG-IL-10
BR112015026122A8 (pt) 2013-04-18 2020-01-21 Armo Biosciences Inc agente de polietileno glicol-il-10 (peg-il-10), seu uso, composição farmacêutica, contentor estéril e kit
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
WO2016064817A1 (en) 2014-10-22 2016-04-28 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
EP3341012A4 (en) 2015-08-25 2019-03-20 Armo Biosciences, Inc. METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
WO2023072850A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68836B1 (en) * 1991-01-16 1996-07-10 Schering Corp Use of interleukin-10 in adoptive immunotherapy of cancer
CZ282523B6 (cs) * 1991-01-16 1997-07-16 Schering Corporation Iterleukin - 10 pro léčení nádorů, farmaceutický prostředek jej obsahující, jeho použití a způsob výroby
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
FI962813A (fi) 1996-07-11
AU5842594A (en) 1995-08-08
NZ259584A (en) 1998-01-26
EP0740552A1 (en) 1996-11-06
AU707019B2 (en) 1999-07-01
SK91696A3 (en) 1997-04-09
PL175343B1 (pl) 1998-12-31
PL315513A1 (en) 1996-11-12
JPH09508116A (ja) 1997-08-19
CN1142186A (zh) 1997-02-05
WO1995019780A1 (en) 1995-07-27
NO963029L (no) 1996-09-19
NO963029D0 (no) 1996-07-19

Similar Documents

Publication Publication Date Title
FI962813A0 (fi) IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen
FR2612939B1 (fr) Equivalent de peau
ATA47787A (de) Festes mundpflegemittel gegen zahnstein und mundgeruch
FR2623396B1 (fr) Utilisation de l'ademetionine contre le vieillissement de la peau
PT86946A (pt) Skin care compositions
DK295190A (da) Kosmetik- og hudbehandlingssammensaetninger
DE3786714D1 (de) Therapeutisches mittel fuer hautgeschwuere.
KR880005157A (ko) 아크릴계 공중합체 및 피부보호제
DK489587D0 (da) Medicinsk hudpraeparat
KR890701004A (ko) 개선된 생리효과를 가지는 식물의 제조 및 이 식물의 용도
ZA94212B (en) Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity
DE3650451D1 (de) Geisteskrankheittherapeutisches Mittel
IT8548663A0 (it) Impiego di acetil l-carnitina nel trattamento terapeutico degli statidi shock
HU9601989D0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
IT8667858A0 (it) Pannolino monouso
DK210187A (da) Medicinsk tampon
FR2594690B1 (fr) Compositions regeneratrices et stimulantes du derme
FI950951A (fi) Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi
IT8628950V0 (it) Cabina per asciugare il corpo umano
ATE51517T1 (de) Rollstuhl und anwendungsweise.
GB9701919D0 (en) Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1
NO171951C (no) Anordning for tilfoering av virksomme stoffer til huden
SE8502549D0 (sv) Hudbehandlingsmedel
ES294556Y (es) Envase suministrador de toallas y similares
DK379184D0 (da) Hudplejemiddel